Clinical trials
Lymphoma, B-Cell, Marginal Zone trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 10 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 3 |
| BeiGene | 2 |
| Gilead Sciences | 2 |
| Incyte Corporation | 2 |
| MEI Pharma, Inc. | 2 |
| Regeneron Pharmaceuticals | 2 |
| AbbVie | 1 |
| Baxalta now part of Shire | 1 |
| CRISPR Therapeutics AG | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 36 |
| Lymphoma, Follicular | 27 |
| Lymphoma, Mantle-Cell | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 17 |
| Lymphoma, Non-Hodgkin | 17 |
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Waldenstrom Macroglobulinemia | 12 |
| Lymphoma | 11 |
| Lymphoma, B-Cell | 6 |
| Recurrence | 4 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.